Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q3 2017 · —
Revenue$2.22B$2.22B+6.0% vs Q3 2016 Net Income$283.00M$283.00M+24.1% vs Q3 2016 EPS Diluted$0.20$0.20+17.6% vs Q3 2016 Gross Profit$1,585,000,000+4.9% Operating Income$377,000,000+8.3% Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
$452,000,000
N/M
Free Cash Flowderived$392,000,000N/M Margins · derivedGross margin71.3%−0.8 pt vs Q3 2016
Operating margin17.0%+0.4 pt vs Q3 2016
Net margin12.7%+1.9 pt vs Q3 2016